SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-13-027214
Filing Date
2013-05-09
Accepted
2013-05-09 08:20:31
Documents
12
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q v342541_10q.htm 10-Q 650972
2 EX-10.1 v342541_ex10-1.htm EX-10.1 56094
3 EX-31.1 v342541_ex31-1.htm EX-31.1 7037
4 EX-31.2 v342541_ex31-2.htm EX-31.2 7042
5 EX-32.1 v342541_ex32-1.htm EX-32.1 3296
6 EX-32.2 v342541_ex32-2.htm EX-32.2 3217
  Complete submission text file 0001144204-13-027214.txt   6125478

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA bcli-20130331.xsd EX-101.SCH 76790
8 XBRL INSTANCE DOCUMENT bcli-20130331.xml EX-101.INS 894388
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bcli-20130331_cal.xml EX-101.CAL 28970
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bcli-20130331_def.xml EX-101.DEF 253321
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE bcli-20130331_lab.xml EX-101.LAB 456982
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bcli-20130331_pre.xml EX-101.PRE 288919
Mailing Address 605 THIRD AVENUE 34TH FLOOR NEW YORK NY 10158
Business Address 605 THIRD AVENUE 34TH FLOOR NEW YORK NY 10158 646-666-3188
BRAINSTORM CELL THERAPEUTICS INC. (Filer) CIK: 0001137883 (see all company filings)

IRS No.: 208133057 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54365 | Film No.: 13826587
SIC: 2836 Biological Products, (No Diagnostic Substances)